Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa' (2006)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- Subjects: LEUCEMIA; ONCOGENES
- Language: Inglês
- Imprenta:
- Publisher place: Basingstoke
- Date published: 2006
- Source:
-
ABNT
REGO, Eduardo Magalhães et al. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'. Oncogene, v. 25, n. 13, p. 1974-1979, 2006Tradução . . Acesso em: 19 abr. 2024. -
APA
Rego, E. M., Ruggero, D., Tribioli, C., Cattoretti, G., Kogan, S., Redner, R. L., & Pandolfi, P. P. (2006). Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'. Oncogene, 25( 13), 1974-1979. -
NLM
Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'. Oncogene. 2006 ; 25( 13): 1974-1979.[citado 2024 abr. 19 ] -
Vancouver
Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR'alfa', PLZF/RAR'alfa' or NPM/RAR'alfa'. Oncogene. 2006 ; 25( 13): 1974-1979.[citado 2024 abr. 19 ] - Trangenic mice expressing hCG-NuMA-RAR'alfa' develop hematopoietic abnormalities leading to acute promyelocytic leukemia
- Role od promyelocytic leukemia (PML) protein in tumor suppression
- Estudo da relevância da inativação do CCAAT enhancer binding protein 'alfa' (C/EBP'alfa') na gênese da leucemia promielocítica
- Linfomas não Hodgkin de células T maduras e de células NK extramodais
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- Anemia e palidez
- Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
